Moderator: Michael N. Blackton, MBA, Vice President, Quality, Adaptimmune LLC
Join us for an in-depth exploration of the current state of development and regulatory thought for the advancement of advanced therapy medicinal products globally.
This webinar will examine cell and gene therapy product development and innovation in a way that helps foster understanding of the evolving landscape of global regulatory requirements in order to advance these therapies through approval and beyond.
Following two presentations by leaders in the field, get your questions answered during a live 30-minute Q&A session with the speakers.
This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month.